Sage Therapeutics, Inc. Quarterly Other Assets, Noncurrent in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Sage Therapeutics, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q1 2019 to Q3 2024.
  • Sage Therapeutics, Inc. Other Assets, Noncurrent for the quarter ending September 30, 2024 was $5.18M, a 21.5% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $5.18M -$1.42M -21.5% Sep 30, 2024 10-Q 2024-10-29
Q2 2024 $7.8M +$911K +13.2% Jun 30, 2024 10-Q 2024-07-31
Q1 2024 $6.22M +$1.96M +46.1% Mar 31, 2024 10-Q 2024-04-25
Q4 2023 $6.55M +$1.78M +37.3% Dec 31, 2023 10-Q 2024-10-29
Q3 2023 $6.59M +$1.68M +34.3% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $6.89M +$1.98M +40.4% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $4.26M -$336K -7.32% Mar 31, 2023 10-Q 2023-05-02
Q4 2022 $4.77M +$519K +12.2% Dec 31, 2022 10-K 2024-02-14
Q3 2022 $4.91M +$1.03M +26.7% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $4.91M +$1.31M +36.3% Jun 30, 2022 10-Q 2022-08-02
Q1 2022 $4.59M +$1.2M +35.3% Mar 31, 2022 10-Q 2022-05-03
Q4 2021 $4.25M +$910K +27.2% Dec 31, 2021 10-K 2023-02-16
Q3 2021 $3.88M +$448K +13.1% Sep 30, 2021 10-Q 2021-11-02
Q2 2021 $3.6M +$184K +5.39% Jun 30, 2021 10-Q 2021-08-03
Q1 2021 $3.39M -$302K -8.18% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 $3.34M -$452K -11.9% Dec 31, 2020 10-K 2022-02-24
Q3 2020 $3.43M -$391K -10.2% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $3.42M -$608K -15.1% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $3.69M -$684K -15.6% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $3.79M Dec 31, 2019 10-K 2021-02-24
Q3 2019 $3.82M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $4.02M Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $4.38M Mar 31, 2019 10-Q 2019-05-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.